These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2679683

  • 1. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR, Heilmann F, Werner H.
    Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H, Heizmann W, Heilmann F.
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [Abstract] [Full Text] [Related]

  • 4. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
    Leone F, Morandotti MG, Mazzella P, Sanna A, Ravizzola G, Colombrita D, Pinzi G, Turano R, Menozzi MG, Lecchini R.
    J Int Med Res; 1990 Jul; 18(3):191-200. PubMed ID: 2193834
    [Abstract] [Full Text] [Related]

  • 5. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 6. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP, Sidorenko SV, Budanov SV.
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [Abstract] [Full Text] [Related]

  • 7. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM, Goldstein EJ, Kenner MA, Burnham LB, Inderlied CB.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [Abstract] [Full Text] [Related]

  • 8. Patterns of resistance to anaerobic organisms in Australia.
    Munro R.
    Diagn Microbiol Infect Dis; 1989 Jun; 12(4 Suppl):159S-163S. PubMed ID: 2591175
    [Abstract] [Full Text] [Related]

  • 9. Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin.
    Borrero E, Rossini M.
    Angiology; 1992 Apr; 43(4):357-61. PubMed ID: 1558322
    [Abstract] [Full Text] [Related]

  • 10. In-vitro activity of ampicillin/sulbactam against cefoxitin-resistant anaerobic bacteria.
    Jones RN, Barry AL.
    J Antimicrob Chemother; 1988 Jan; 21(1):135-8. PubMed ID: 3356620
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U, Manncke B, Gerbracht K, Werner H.
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
    Heizmann WR, Heilmann F, Egeler B, Werner H.
    Infection; 1990 Jul; 18(2):117-21. PubMed ID: 2332245
    [Abstract] [Full Text] [Related]

  • 14. Ampicillin plus sulbactam in vitro activity against anaerobes.
    Heilmann F, Heizmann W, Werner H.
    Drugs; 1988 Jul; 35 Suppl 7():84-8. PubMed ID: 3220012
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
    Lawrenz CA, Cole P, Theodorou A, Cook RL, Bermann L.
    Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
    [Abstract] [Full Text] [Related]

  • 16. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN.
    Diagn Microbiol Infect Dis; 1990 Oct; 13(4):353-5. PubMed ID: 2076598
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
    Sullivan MC, Nightingale CH, Quintiliani R, Sweeney KR.
    Pharmacotherapy; 1995 Oct; 15(4):479-86. PubMed ID: 7479201
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV, Botta GA, Pesce A, Schito GC.
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.